Novartis AIN457 meets primary endpoint in two Phase III studies in ankylosing spondylitis
First selective IL-17A inhibitor to meet primary endpoint in two pivotal Phase III studies showing improvement in active…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 436
Browsing Category
Latest Updates
CSI with SIES Institute of Chromatography and Spectroscopy to organise symposium
Symposium to be held in Navi Mumbai on December 18 and 19, 2014
CSI with SIES Institute of Chromatography and Spectroscopy to organise symposium
Symposium to be held in Navi Mumbai on December 18 and 19, 2014
MSF urges immediate action on Ebola vaccines and treatments for frontline workers
Significant investment and incentives are needed now to accelerate these steps
MSF urges immediate action on Ebola vaccines and treatments for frontline workers
Significant investment and incentives are needed now to accelerate these steps
AbbVie named top employer in Science magazine’s annual survey
Honoured as the best employer for the second consecutive year by the magazine
Novartis AIN457 meets primary endpoint in two Phase III studies in ankylosing spondylitis
First selective IL-17A inhibitor to meet primary endpoint in two pivotal Phase III studies showing improvement in active…
Roche to invest 3 billion Swiss francs in its Basel site
Switzerland-based drugmaker Roche will invest 3 billion Swiss francs in the construction of a new research and development centre…
Biocon posts Rs 773 crores revenue in Q2 FY15
Branded formulations records strong growth of 17 per cent
Indoco Remedies Q2 PAT grows by 40 per cent
Domestic formulation business revenues grew by 14 per cent at Rs 137.4 crores